Unknown

Dataset Information

0

Genomic characterization of patients with polycythemia vera developing resistance to hydroxyurea.

ABSTRACT:

SUBMITTER: Alvarez-Larran A 

PROVIDER: S-EPMC7862052 | biostudies-literature | 2021 Feb

REPOSITORIES: biostudies-literature

Json Xml

Similar Datasets

Unknown Identifying Patients with Polycythemia Vera at Risk of Thrombosis after Hydroxyurea Initiation: The Polycythemia Vera-Advanced Integrated Models (PV-AIM) Project.
| S-EPMC10377437 | biostudies-literature
Unknown Real-world analysis of main clinical outcomes in patients with polycythemia vera treated with ruxolitinib or best available therapy after developing resistance/intolerance to hydroxyurea.
| S-EPMC9324831 | biostudies-literature
Unknown Where to Turn for Second-Line Cytoreduction After Hydroxyurea in Polycythemia Vera?
| S-EPMC4828120 | biostudies-literature
Unknown Risk of thrombosis according to need of phlebotomies in patients with polycythemia vera treated with hydroxyurea.
| S-EPMC5210240 | biostudies-literature
Unknown The impact of phlebotomy and hydroxyurea on survival and risk of thrombosis among older patients with polycythemia vera.
| S-EPMC6199652 | biostudies-literature
Unknown Pegylated interferon alfa-2a for polycythemia vera or essential thrombocythemia resistant or intolerant to hydroxyurea.
| S-EPMC6839950 | biostudies-literature
Unknown A randomized phase 3 trial of interferon-α vs hydroxyurea in polycythemia vera and essential thrombocythemia.
| S-EPMC9101248 | biostudies-literature
Unknown Impact of ELN clinical signs and symptoms on the thrombotic risk in polycythemia vera patients treated with front-line hydroxyurea.
| S-EPMC12310514 | biostudies-literature
Unknown Volumetric Splenomegaly in Patients With Polycythemia Vera.
| S-EPMC8938613 | biostudies-literature
Unknown Oral idasanutlin in patients with polycythemia vera.
| S-EPMC6688433 | biostudies-literature